Cover image of the article: Molecular mechanism of insulin resistance

Image Credit:J Inflamm Dis

Molecular mechanism of insulin resistance

Authors

Mohammad Reza Sarookhani1,*, E Arefian2
1QUMS
2Tehran University
*Corresponding Author: QUMS Email: mrsarookhani@qums.ac.ir

Journal of Inflammatory Diseases:Vol. 18, issue 5; 57-64
Published online:Dec 16, 2014
Article type:Review Article
How to Cite:Sarookhani MR, Arefian E. Molecular mechanism of insulin resistance. J Inflamm Dis. 2024;18(5):e155862. doi:

Abstract

  Type 2 diabetes is of particular importance as one of the main causes of cardiovascular diseases, renal dysfunction and their related mortality. Two main characteristics of the disease are insulin secretion defects and insulin resistance. It seems that insulin resistance is a key trigger in the pathogenesis of the disease. It is reasonable to think about how to prevent the incidence of type 2 diabetes, reduce its severity and morbidity and to postpone the disease onset by studying the molecular mechanism of insulin resistance in order to inhibit or reduce the driving proteins behind insulin resistance and to find appropriate therapeutic approaches especially based on RNAs regulating gene expression.   This review focuses on recent published molecular findings about occurrence of insulin resistance using genetic databases such as KEGG GENES and OMIM to introduce the trigger mechanism of type 2 diabetes.     

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

4
Oct
2005
Insulin Resistance Syndrome (Syndrome X)

Insulin Resistance Syndrome (Syndrome X)

F Karimi

Karimi F. Insulin Resistance Syndrome (Syndrome X). Shiraz E-Med J. 2005;6(3 and 4):32898. doi:

27
May
2013
Acanthosis nigricans, Abnormal Facial Appearance and Dentition in an Insulin Resistance Syndrome

Acanthosis nigricans, Abnormal Facial Appearance and Dentition in an Insulin Resistance Syndrome

Ahya Zaridoust,
Ali Rabbani,
Fatemeh Sayarifard,
Christian T. Thiel,
Nima Rezaei

Zaridoust A, Rabbani A, Sayarifard F, T. Thiel C, Rezaei N. Acanthosis nigricans, Abnormal Facial Appearance and Dentition in an Insulin Resistance Syndrome. Inn J Pediatr. 2013;23(3):. doi:

2
Jul
2022
A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases

Nabil W. G. Sweis,
Ahmad Albanna,
Rama Alhasoun,
Ayman Zayed

Sweis NWG, Albanna A, Alhasoun R, Zayed A. A Possible Novel Effect for Dapagliflozin in the Management of Subcutaneous Insulin Resistance Syndrome: A Report of Two Cases. Int J Endocrinol Metab. 2022;20(3):e126350. doi: https://doi.org/10.5812/ijem-126350

2
Sep
2022
Pharmacogenomic approach in type 2 diabetes treatment

Pharmacogenomic approach in type 2 diabetes treatment

Negar Sarhangi,
Fatemeh Rahbar,
Mandana Hasanzad

Sarhangi N, Rahbar F, Hasanzad M. Pharmacogenomic approach in type 2 diabetes treatment. koomesh. 2022;24(2):e152666. doi:

1
Jul
2013
Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future

Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future

Carlo Maria Rotella,
Laura Pala,
Edoardo Mannucci

Maria Rotella C, Pala L, Mannucci E. Role of Insulin in the Type 2 Diabetes Therapy: Past, Present and Future. Int J Endocrinol Metab. 2013;11(3):137-144. doi: https://doi.org/10.5812/ijem.7551

More by these authors

Mohammad Reza SarookhaniPubMedScholar
E ArefianPubMedScholar
Share
Cited by
Metrics